Intravenous Quetiapine-Cocaine Use (“Q-Ball”)

Waters, Brian M.; Joshi, Kaustubh G.

doi:10.1176/ajp.2007.164.1.173a

Cited by 42 publications

(18 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Ours is one of the few qualitative studies that examine misuse of quetiapine among drug users (Incardi et al, 2007;Kecojevic et al, 2015;Malekshahi, Tioleco, Ahmed, Campbell & Haller, 2015). Since quetiapine obtained market approval in 1997, there has been an increasing number of case reports suggesting it has a misuse/abuse potential (Haridas et al, 2010;Hussain et al, 2005;Keltner & Vance, 2008;Morin, 2007;Murphy, Bailey, Stone & Wirshing, 2008;Pierre, Shnayder, Wirshing & Wirshing, 2004;Pinta & Taylor, 2007;Reeves & Brister, 2007;Waters & Joshi, 2007). Several reports have emphasized that individuals in institutional settings (psychiatric units and prisons) show drug-seeking behaviours or mimic psychiatric symptoms to obtain quetiapine, and use alternative routes to administer it.…”

Section: Discussionmentioning

confidence: 99%

“I love having benzos after my coke shot”: The use of psychotropic medication among cocaine users in downtown Montreal

Motta-Ochoa

Bertrand

Arruda

et al. 2017

International Journal of Drug Policy

View full text Add to dashboard Cite

PM use practices showed several complementary functions that PM fulfill in a context of polydrug use. The soothing and stimulating effects of PM reinforce the patterns of drug use among participants, posing various risks including overdose, HIV/HCV transmission, PM dependence and accidents. The results highlight the need for clinicians to assess clients' substance use patterns when prescribing PM and to question PWUC about PM use. The findings also underline certain unmet service needs in relation to overdose, HIV/HCV and mental health prevention/treatment among cocaine users.

show abstract

Section: Discussionmentioning

confidence: 99%

“I love having benzos after my coke shot”: The use of psychotropic medication among cocaine users in downtown Montreal

Motta-Ochoa

Bertrand

Arruda

et al. 2017

International Journal of Drug Policy

View full text Add to dashboard Cite

show abstract

“…52 Similarly, atypical antipsychotics, specifically quetiapine, olanzapine, and risperidone are mentioned in association with methadone and buprenorphine use. Que-tiapine has been reported to be abused by injection and nasal insufflation, particularly with cocaine in a combination referred to as a “Q-ball.” 53 It is an inhibitor of CYP 450 2D6 and is an inhibitor of the efflux transporter p-glycoprotein. 54 Quetiapine should not be considered a first-line treatment of anxiety or psychosis in methadone or buprenorphine-maintained patients.…”

Section: Discussionmentioning

confidence: 99%

Indicators of Buprenorphine and Methadone Use and Abuse: What Do We Know?

Maxwell

McCance‐Katz

2009

American J Addict

View full text Add to dashboard Cite

Abuse of prescription opioids is a growing problem. The number of methadone pain pills distributed now exceeds liquid methadone used in opioid treatment, and the increases in buprenorphine indicators provide evidence of the need to monitor and intervene to decrease the abuse of this drug. The need for additional and improved data to track trends is discussed, along with findings as to the characteristics of the users and combinations of drugs. Data on toxicities related to methadone or buprenorphine, particularly in combination with other prescribed drugs, are presented and clinical implications and considerations are offered. These findings underscore the need for physicians to be aware of potential toxicities and to educate their patients regarding these issues.

show abstract

“…Other types of substances or medications, both new (Spice [synthetic cannabinoid][113,114]) and old (quetiapine [Seroquel ® ][115] and carisoprodol [Soma ® ][116]), have potential for abuse as well and can typically be tested through LC‐MS/MS.…”

Section: Introductionmentioning

confidence: 99%

Interpretation of Urine Drug Testing in Pain Patients

et al. 2012

View full text Add to dashboard Cite

Background. Traditionally, urine drug screens have only been concerned with positive or negative results. Those results provide physicians treating patients for pain with chronic opioid therapy with information about medication compliance, use of nonprescribed medications, and use of illicit drugs. However, the analysis of urine for drugs offers additional information that, when compiled and accurately interpreted, may also be of great value to these doctors. Purpose: The aim of this article was to discuss the interpretation of urine drug tests and their application to pain physician practices. Method. We utilized a selection of recent articles on urine drug screening applicable to the pain patient population. Results and Conclusions. The article provides pertinent information about interpretation of urine drug testing, which is separated into six categories: which drugs and metabolites to test for; which analytical cutoffs to use; pain medication metabolism; identification of alcohol use; determination of patient compliance; and which patient groups to consider for more frequent testing.

show abstract

Intravenous Quetiapine-Cocaine Use (“Q-Ball”)

Cited by 42 publications

References 10 publications

“I love having benzos after my coke shot”: The use of psychotropic medication among cocaine users in downtown Montreal

“I love having benzos after my coke shot”: The use of psychotropic medication among cocaine users in downtown Montreal

Indicators of Buprenorphine and Methadone Use and Abuse: What Do We Know?

Interpretation of Urine Drug Testing in Pain Patients

Contact Info

Product

Resources

About